Financière de Tubize SA (TUB.BR)

EUR 138.8

(-0.86%)

Net Income Summary of Financière de Tubize SA

  • Financière de Tubize SA's latest annual net income in 2023 was 88.15 Million EUR , down -49.4% from previous year.
  • Financière de Tubize SA's latest quarterly net income in 2024 Q2 was 92.93 Million EUR , down 0.0% from previous quarter.
  • Financière de Tubize SA reported an annual net income of 174.22 Million EUR in 2022, down -54.16% from previous year.
  • Financière de Tubize SA reported an annual net income of 380.09 Million EUR in 2021, up 45.9% from previous year.
  • Financière de Tubize SA reported a quarterly net income of -2.91 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • Financière de Tubize SA reported a quarterly net income of 91.06 Million EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Net Income Chart of Financière de Tubize SA (2023 - 2003)

Historical Annual Net Income of Financière de Tubize SA (2023 - 2003)

Year Net Income Net Income Growth
2023 88.15 Million EUR -49.4%
2022 174.22 Million EUR -54.16%
2021 380.09 Million EUR 45.9%
2020 260.51 Million EUR 23891.69%
2019 -1.09 Million EUR -100.38%
2018 285.15 Million EUR -0.27%
2017 285.93 Million EUR 57.81%
2016 181.18 Million EUR -14.75%
2015 212.52 Million EUR 249.29%
2014 60.84 Million EUR -1.4%
2013 61.7 Million EUR -20.7%
2012 77.81 Million EUR 20.29%
2011 64.68 Million EUR 209.97%
2010 20.86 Million EUR -87.22%
2009 163.3 Million EUR 18145.08%
2008 -905 Thousand EUR -102.29%
2007 39.53 Million EUR -91.72%
2006 477.27 Million EUR 62.42%
2005 293.85 Million EUR 137.16%
2004 123.9 Million EUR 4.92%
2003 118.09 Million EUR 0.0%

Peer Net Income Comparison of Financière de Tubize SA

Name Net Income Net Income Difference
ABIONYX Pharma SA -3.51 Million EUR 2605.721%
ABIVAX Société Anonyme -147.74 Million EUR 159.666%
Adocia SA -21.16 Million EUR 516.555%
Aelis Farma SA -5.07 Million EUR 1835.945%
Biophytis S.A. -17.02 Million EUR 617.745%
Advicenne S.A. -7.03 Million EUR 1353.751%
genOway Société anonyme 1.56 Million EUR -5523.416%
IntegraGen SA -171.39 Thousand EUR 51530.444%
Medesis Pharma S.A. -3.95 Million EUR 2326.328%
Neovacs S.A. -8.74 Million EUR 1108.198%
NFL Biosciences SA -3.74 Million EUR 2453.54%
Plant Advanced Technologies SA 79.16 Thousand EUR -111245.687%
Quantum Genomics Société Anonyme -3.17 Million EUR 2879.967%
Sensorion SA -22.06 Million EUR 499.536%
Theranexus Société Anonyme -6.82 Million EUR 1391.035%
TME Pharma N.V. -6.73 Million EUR 1408.659%
Valbiotis SA -7.36 Million EUR 1296.407%
TheraVet SA -1.57 Million EUR 5712.203%
Valerio Therapeutics Société anonyme -20.34 Million EUR 533.304%
argenx SE -272.91 Million EUR 132.3%
BioSenic S.A. -28.77 Million EUR 406.315%
Celyad Oncology SA -8.44 Million EUR 1143.457%
DBV Technologies S.A. -67.26 Million EUR 231.042%
Galapagos NV 211.69 Million EUR 58.36%
Genfit S.A. -28.89 Million EUR 405.085%
GeNeuro SA -14.75 Million EUR 697.352%
Hyloris Pharmaceuticals SA -15.38 Million EUR 673.155%
Innate Pharma S.A. -7.57 Million EUR 1264.482%
Inventiva S.A. -110.42 Million EUR 179.828%
MaaT Pharma SA -19.71 Million EUR 547.083%
MedinCell S.A. -25.03 Million EUR 452.07%
Nanobiotix S.A. -39.7 Million EUR 322.043%
Onward Medical N.V. -36.18 Million EUR 343.64%
Oryzon Genomics S.A. -3.35 Million EUR 2729.071%
OSE Immunotherapeutics SA -23 Million EUR 483.216%
Oxurion NV -18.96 Million EUR 564.712%
Pharming Group N.V. -9.75 Million EUR 1003.505%
Poxel S.A. -35.09 Million EUR 351.215%
GenSight Biologics S.A. -26.22 Million EUR 436.199%
Transgene SA -22.32 Million EUR 494.801%
UCB SA 343 Million EUR 74.3%
Valneva SE -101.42 Million EUR 186.909%
Vivoryon Therapeutics N.V. -28.34 Million EUR 411.027%